Related Experiment Video

Updated: May 7, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Early surfactant for respiratory distress syndrome in premature infants

Fabio Scopesi1, Alessandro Parodi, Anna R Natalizia

  • 1Neonatal Intensive Care Unit, Istituto Giannina Gaslini, Via Gaslini 5, 16148 Genova, Italy. fabio.scopesi@yahoo.it

Acta Bio-Medica : Atenei Parmensis
|September 21, 2013
PubMed

Insights

Early surfactant administration in premature newborns is well-studied. A tailored approach, considering risk factors, may be better than standardized respiratory care at birth for these infants.

Area of Science:

  • Neonatal Medicine
  • Respiratory Care
  • Pediatric Pulmonology

Background:

  • Surfactant therapy is crucial for premature infants with respiratory distress syndrome.
  • Numerous randomized controlled trials (RCTs) and meta-analyses have examined surfactant administration timing and strategies.
  • Current evidence compares early versus delayed and selective versus prophylactic surfactant use.

Purpose of the Study:

  • To review existing literature on early surfactant administration in premature newborns.
  • To discuss factors influencing the standardization of respiratory care at birth.
  • To propose a risk-factor-based tailored approach for surfactant therapy.

Main Methods:

  • Literature review of RCTs and meta-analyses on surfactant administration.
  • Discussion of factors challenging standardized respiratory care protocols.
  • Analysis of patient heterogeneity in the premature newborn population.

Main Results:

  • Early surfactant administration effects are extensively documented.
  • Comparisons between early/delayed and selective/prophylactic strategies exist.
  • Standardization of respiratory care is debated due to infant variability.

Conclusions:

  • A one-size-fits-all approach to respiratory care at birth may not be optimal.
  • Stratifying premature newborns by risk factors can guide individualized surfactant therapy.
  • Tailored respiratory support is essential for the heterogeneous population of preterm infants.

More Related Videos

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Surface Active Agents01:27

Surface Active Agents

Surfactants, named for their behavior at interfaces, positively adsorb at the interfaces of two phases, reducing interfacial tension. Their versatility as emulsifiers, detergents, and foaming agents stems from this ability. Surfactants, often termed amphiphiles, share the property of amphipathy, with molecules having both hydrophilic and hydrophobic portions. The hydrophilic part is called the head, and the hydrophobic part, including an elongated alkyl substituent, forms the tail.Surfactants...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...